UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) March 926, 2009

LIFE SCIENCES, INC.

(Exact name of registrant as specified in its charter)

Delaware

000-05099

59-0995081

(State or other jurisdiction

of incorporation)

(Commission File Number)

(IRS Employer

Identification No.)


2900 – 72nd Street North, St. Petersburg, Florida		33710
(Address of principal executive offices)		(Zip Code)

Registrant’s telephone number, including area code (727) 345-9371

Not applicable

(Former name or former address, if changed since last report.)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

¨	Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

¨	Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

¨	Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

¨	Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Exhibit Index at Page 4

Non Regulation FD Filing

This Form 8-K is being filed for reasons other than those that would require a filing under Regulation FD.

Item 8.01.

Other Events.

On March 926, 2009, Life Sciences, Inc. ~~filed~~received a ~~voluntary~~document ~~petition~~dated ~~for~~March 25, ~~relief~~2009 ~~under~~and ~~Chapter~~entitled 11“Consent of ~~the~~Stockholders” ~~United~~that ~~State~~purported ~~Bankruptcy~~to ~~Code~~elect ~~(reorganization)~~Robert inAldrich ~~the~~and UTerry A.S McHugh as directors of Life Sciences. ~~Bankruptcy~~The ~~Court~~document ~~for~~was received from Robert W. Berend, Esquire, of the ~~Middle~~New ~~District~~York law firm of ~~Florida~~Wachtel & Maryr, ~~Tampa Division~~LLP. ToThat ~~obtain~~firm ~~related~~has ~~funds~~represented ~~for~~Simon Srybnik and various interests controlled by him and his brother Louis D. Srybnik (collectively, the ~~proceeding~~“Srybnik Interests”) in actions with ~~Tampa,~~respect to Life Sciences, ~~issued~~including onthe ~~March 9,~~August ~~2009,~~2008 ~~its~~lawsuit ~~$35,000,~~brought ~~30-day,~~in ~~promissory~~New ~~note~~York ~~and~~for amore ~~warrant~~than to9 ~~purchase~~years ~~700,000~~of ~~shares~~allegedly ofdue ~~Life~~back ~~Sciences~~rent on the Company’s ~~common~~manufacturing, ~~stock~~laboratory toand aoffice ~~single~~facilities ~~foreign~~in ~~investor~~St. Petersburg, Florida.

~~The~~Simon ~~Chapter~~Srybnik 11resigned ~~filing~~on ~~had~~November 6, ~~the~~2008 ~~effect~~as ~~under~~a ~~the~~director ~~automatic~~and ~~stay~~officer ~~provisions~~ of the ~~Bankruptcy~~Company ~~Code~~after ofserving ~~stopping,~~in ~~pending~~those ~~further~~capacities ~~order~~for ofmore ~~court,~~than ~~the~~40 ~~eviction~~years, ofincluding ~~Life~~as ~~Sciences~~Chairman ~~from~~of ~~its~~the ~~manufacturing~~Board, ~~laboratory~~Chief ~~and~~Executive ~~office~~Officer ~~facilities~~and inPresident ~~St.~~for ~~Petersburg,~~more ~~Florida~~than ~~otherwise~~the ~~scheduled for March~~ 10, ~~2009.~~years ~~That~~preceding ~~eviction~~his ~~would~~resignation. ~~have~~Together ~~taken~~the ~~place pursuant to a judgment obtained against Life Sciences in a Florida state court by Simon~~ Srybnik ~~and~~Interests ~~Louis~~own D.approximately ~~Srybnik~~60% ~~through~~of ~~their~~the ~~controlled~~outstanding ~~New~~common ~~York~~stock ~~corporation, 186-194 Imlay St. Realty Corp. (“Imlay”), on March 5, 2009 related to 9-1/2 years~~ of ~~allegedly~~Life ~~due back rent~~Sciences.

~~Simon~~By ~~and~~letter ~~Louis~~dated DMarch 30, 2009, Life Sciences advised Mr. Berend ~~Srybnik~~of ~~not~~the ~~only~~invalidity ~~control~~of ~~Imlay,~~the ~~but~~purported ~~also~~election ~~are~~by the ~~direct~~Srybnik Interests of Mr. Aldrich and ~~indirect~~Mr. McHugh ~~beneficial~~as ~~owners~~directors of ~~more~~the ~~than~~Company. ~~60%~~The reasons for the invalidity of the ~~common~~Srybnik ~~stock~~Interests’ “Consent of Stockholders” includes the long-standing provision of Life Sciences’ Bylaws to the effect that the stockholders of the Company may only take action by written consent if all of the stockholders consent in writing to the corporate action.

~~See~~The ~~also,~~letter ~~among~~to ~~other matters, the Forms 8-K filed by Life Sciences with the Securities and Exchange Commission on November~~Mr. ~~10,~~Berend ~~2008~~also ~~(cover~~contained ~~and~~reminders ~~signed dates~~ of ~~September 16,~~the ~~2008~~duties ~~and November 10, 2008), November 26, 2008 (cover and signed dates~~ of ~~November 20,~~the ~~2008~~Srybnik ~~and~~Interests ~~November 26,~~to ~~2008), December 2,~~comply ~~2008~~with ~~(cover~~the ~~and signed~~applicable ~~dates~~requirements of ~~November 26,~~Sections ~~2008 and December 2, 2008~~13(d)~~, January 9,~~ ~~2009 (cover~~ and ~~signed~~16 ~~dates~~ of ~~January 5,~~the ~~2009~~Securities ~~and~~Exchange ~~January 9,~~Act ~~200), and March 9, 2009 (cover and signed dates~~ of ~~March 5, 2009 and March 9, 2009)~~1934.

The details of the “Consent of Stockholders” and the Company’s March 30, 2009 response are set forth in the attached Exhibit 99.03, which is incorporated herein by this reference.

See also, among other matters, the Forms 8-K filed by Life Sciences with the Securities and Exchange Commission on November 10, 2008 (cover and signed dates of September 16, 2008 and November 10, 2008), November 26, 2008 (cover and signed dates of November 20, 2008 and November 26, 2008), December 2, 2008 (cover and signed dates of November 26, 2008 and December 2, 2008), January 9, 2009 (cover and signed dates of January 5, 2009 and January 9, 200), March 9, 2009 (cover and signed dates of March 5, 2009 and March 9, 2009), and March 12, 2009 (cover and signed dates of March 9, 2009 and March 12, 2009).

Item 9.01.

Financial statements and Exhibits.

(d)

Exhibits.

Exhibit 99.03 (letter dated March 30, 2002 from Life Sciences, Inc. to counsel for the Srybnik Interests, with attached “Consent of Stockholders” dated March 25, 2009) is attached and incorporated in this Form 8-K by this reference.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: March 1231, 2009.

LIFE SCIENCES, INC. By: /s/ ~~Alex~~ALEX A. ~~Burns~~BURNS Alex A. Burns, Vice President and Secretary

EXHIBIT INDEX


Exhibit No.	Description	Beginning At Sequential Page No.
99.03	Letter dated March 30, 2002 from Life Sciences, Inc. to counsel for the Srybnik Interests, with attached “Consent of Stockholders” dated March 25, 2009	5

Filing Compare · LIFE SCIENCES INC